VRK3_HUMAN - dbPTM
VRK3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID VRK3_HUMAN
UniProt AC Q8IV63
Protein Name Inactive serine/threonine-protein kinase VRK3
Gene Name VRK3
Organism Homo sapiens (Human).
Sequence Length 474
Subcellular Localization Nucleus .
Protein Description Inactive kinase that suppresses ERK activity by promoting phosphatase activity of DUSP3 which specifically dephosphorylates and inactivates ERK in the nucleus..
Protein Sequence MISFCPDCGKSIQAAFKFCPYCGNSLPVEEHVGSQTFVNPHVSSFQGSKRGLNSSFETSPKKVKWSSTVTSPRLSLFSDGDSSESEDTLSSSERSKGSGSRPPTPKSSPQKTRKSPQVTRGSPQKTSCSPQKTRQSPQTLKRSRVTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPMVP
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Phosphorylation-----MISFCPDCGK
-----CCEECCCCCH
21.3525002506
11PhosphorylationFCPDCGKSIQAAFKF
ECCCCCHHHHHHHHH
12.7625002506
50MethylationSSFQGSKRGLNSSFE
HHCCCCCCCCCCCCC
57.43115919865
54PhosphorylationGSKRGLNSSFETSPK
CCCCCCCCCCCCCCC
41.2522167270
55PhosphorylationSKRGLNSSFETSPKK
CCCCCCCCCCCCCCC
26.4823401153
58PhosphorylationGLNSSFETSPKKVKW
CCCCCCCCCCCCCCC
48.6030266825
59PhosphorylationLNSSFETSPKKVKWS
CCCCCCCCCCCCCCC
27.7619664994
66PhosphorylationSPKKVKWSSTVTSPR
CCCCCCCCCCCCCCC
15.4826853621
67PhosphorylationPKKVKWSSTVTSPRL
CCCCCCCCCCCCCCE
26.2830576142
68PhosphorylationKKVKWSSTVTSPRLS
CCCCCCCCCCCCCEE
23.4526853621
70PhosphorylationVKWSSTVTSPRLSLF
CCCCCCCCCCCEEEC
32.8525159151
71PhosphorylationKWSSTVTSPRLSLFS
CCCCCCCCCCEEECC
12.0425159151
71O-linked_GlycosylationKWSSTVTSPRLSLFS
CCCCCCCCCCEEECC
12.0430379171
75PhosphorylationTVTSPRLSLFSDGDS
CCCCCCEEECCCCCC
28.7522115753
78PhosphorylationSPRLSLFSDGDSSES
CCCEEECCCCCCCCC
46.0825159151
82PhosphorylationSLFSDGDSSESEDTL
EECCCCCCCCCCCCC
41.3525159151
83PhosphorylationLFSDGDSSESEDTLS
ECCCCCCCCCCCCCC
50.2925159151
85PhosphorylationSDGDSSESEDTLSSS
CCCCCCCCCCCCCHH
42.6030278072
88PhosphorylationDSSESEDTLSSSERS
CCCCCCCCCCHHHHC
25.2022115753
90PhosphorylationSESEDTLSSSERSKG
CCCCCCCCHHHHCCC
33.6319690332
91PhosphorylationESEDTLSSSERSKGS
CCCCCCCHHHHCCCC
39.0523403867
92PhosphorylationSEDTLSSSERSKGSG
CCCCCCHHHHCCCCC
33.3823403867
95PhosphorylationTLSSSERSKGSGSRP
CCCHHHHCCCCCCCC
37.0024719451
98PhosphorylationSSERSKGSGSRPPTP
HHHHCCCCCCCCCCC
37.0123403867
100PhosphorylationERSKGSGSRPPTPKS
HHCCCCCCCCCCCCC
43.2223403867
104PhosphorylationGSGSRPPTPKSSPQK
CCCCCCCCCCCCCCC
46.1322617229
107PhosphorylationSRPPTPKSSPQKTRK
CCCCCCCCCCCCCCC
48.7523403867
107O-linked_GlycosylationSRPPTPKSSPQKTRK
CCCCCCCCCCCCCCC
48.7530379171
108PhosphorylationRPPTPKSSPQKTRKS
CCCCCCCCCCCCCCC
37.1623403867
112PhosphorylationPKSSPQKTRKSPQVT
CCCCCCCCCCCCCCC
37.7728111955
115PhosphorylationSPQKTRKSPQVTRGS
CCCCCCCCCCCCCCC
19.7822617229
119PhosphorylationTRKSPQVTRGSPQKT
CCCCCCCCCCCCCCC
24.8625159151
122PhosphorylationSPQVTRGSPQKTSCS
CCCCCCCCCCCCCCC
22.3728355574
126PhosphorylationTRGSPQKTSCSPQKT
CCCCCCCCCCCCCCC
29.7128450419
127PhosphorylationRGSPQKTSCSPQKTR
CCCCCCCCCCCCCCC
21.4528450419
129PhosphorylationSPQKTSCSPQKTRQS
CCCCCCCCCCCCCCC
30.0828450419
133PhosphorylationTSCSPQKTRQSPQTL
CCCCCCCCCCCCCHH
28.7923403867
136PhosphorylationSPQKTRQSPQTLKRS
CCCCCCCCCCHHHHH
18.7130266825
139PhosphorylationKTRQSPQTLKRSRVT
CCCCCCCHHHHHHCC
37.3230266825
143PhosphorylationSPQTLKRSRVTTSLE
CCCHHHHHHCCCCEE
29.5226270265
146PhosphorylationTLKRSRVTTSLEALP
HHHHHHCCCCEECCC
15.0126270265
147PhosphorylationLKRSRVTTSLEALPT
HHHHHCCCCEECCCC
28.5826270265
148PhosphorylationKRSRVTTSLEALPTG
HHHHCCCCEECCCCC
18.1726270265
154PhosphorylationTSLEALPTGTVLTDK
CCEECCCCCCEEECC
46.4626270265
156PhosphorylationLEALPTGTVLTDKSG
EECCCCCCEEECCCC
18.1526270265
159PhosphorylationLPTGTVLTDKSGRQW
CCCCCEEECCCCCEE
36.7226270265
161UbiquitinationTGTVLTDKSGRQWKL
CCCEEECCCCCEEEE
49.96-
161AcetylationTGTVLTDKSGRQWKL
CCCEEECCCCCEEEE
49.9625953088
169UbiquitinationSGRQWKLKSFQTRDN
CCCEEEEEEEECCCC
45.56-
179UbiquitinationQTRDNQGILYEAAPT
ECCCCCCEEEEECCC
2.3921890473
197UbiquitinationTCDSGPQKQKFSLKL
ECCCCCCCCCEEEEE
59.60-
199UbiquitinationDSGPQKQKFSLKLDA
CCCCCCCCEEEEEEC
43.91-
223UbiquitinationNFFQRAAKPLQVNKW
CHHHHHCCCCCCCHH
45.32-
225UbiquitinationFQRAAKPLQVNKWKK
HHHHCCCCCCCHHHH
9.7721890473
229 (in isoform 2)Ubiquitination-62.6321890473
229 (in isoform 1)Ubiquitination-62.6321890473
229UbiquitinationAKPLQVNKWKKLYST
CCCCCCCHHHHHHCC
62.6321890473
232UbiquitinationLQVNKWKKLYSTPLL
CCCCHHHHHHCCCEE
52.09-
268PhosphorylationSLGRSLQSALDVSPK
HHCHHHHHHHCCCHH
35.7730622161
273PhosphorylationLQSALDVSPKHVLSE
HHHHHCCCHHHHCCH
28.0930622161
275 (in isoform 1)Ubiquitination-38.5521890473
275AcetylationSALDVSPKHVLSERS
HHHCCCHHHHCCHHH
38.5523749302
275 (in isoform 2)Ubiquitination-38.5521890473
275UbiquitinationSALDVSPKHVLSERS
HHHCCCHHHHCCHHH
38.5521890473
338UbiquitinationFRYCPSGKHVAYVEG
EEECCCCCEEEEEEC
38.96-
348PhosphorylationAYVEGSRSPHEGDLE
EEEECCCCCCCCCCE
32.1020873877
410UbiquitinationQKQKFVDKPGPFVGP
HHHHHCCCCCCCCCC
46.72-
411 (in isoform 2)Phosphorylation-51.7521406692
439PhosphorylationLKVVMALTYEEKPPY
HHHHHHHHCCCCCCH
21.2429449344
440PhosphorylationKVVMALTYEEKPPYA
HHHHHHHCCCCCCHH
23.9629449344

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
108SPhosphorylationKinaseCDK5Q00535
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of VRK3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of VRK3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TWF2_HUMANTWF2physical
17353931

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of VRK3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59; SER-82; SER-83 ANDSER-90, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-55 AND SER-59, AND MASSSPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136, AND MASSSPECTROMETRY.

TOP